default author photo

Brenda Okech

UVRI-IAVI HIV Vaccine Program

SCHOLARLY PAPERS

3

DOWNLOADS

271

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Safety and Broad Immunogenicity of HIVconsvX Conserved Mosaic Candidate T-Cell Vaccines Vectored by ChAdOx1 and MVA in HIV-CORE 006: A Double-Blind, Randomized, Placebo-Controlled Phase 1 Trial in Healthy Adults Living Without HIV-1 in Eastern and Southern Africa

Number of pages: 24 Posted: 26 Mar 2024
Center for Family Health Research Zambia (CFHRZ), Government of Uganda - Uganda Virus Research Institute (UVRI), University of Nairobi, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, University of Oxford, IAVI, University of Oxford, MRC/UVRI & LSHTM Uganda Research Unit, University of Oxford, University of Nairobi, Center for Family Health Research Zambia (CFHRZ), IAVI, IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, University of Oxford, IAVI, Imperial College London - IAVI Human Immunology Laboratory, London School of Hygiene & Tropical Medicine - Uganda Research Unit, IAVI, University of Oxford, MRC/UVRI & LSHTM Uganda Research Unit, affiliation not provided to SSRN, Imperial College London - IAVI Human Immunology Laboratory, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), affiliation not provided to SSRN, Center for Family Health Research Zambia (CFHRZ), MRC/UVRI & LSHTM Uganda Research Unit, Medical Research Council/Uganda Virus Research Institute & London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM), Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, International AIDS Vaccine Initiative, Imperial College London - IAVI Human Immunology Laboratory, Center for Family Health Research Zambia (CFHRZ), University of Nairobi, University of Nairobi, IAVI, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), London School of Hygiene & Tropical Medicine - Uganda Research Unit, University of Nairobi, MRC/UVRI & LSHTM Uganda Research Unit, Oxus Technologies Limited, University of Nairobi, Center for Family Health Research Zambia (CFHRZ), University of Nairobi, Center for Family Health Research Zambia (CFHRZ), Center for Family Health Research Zambia (CFHRZ), University of Nairobi, MRC/UVRI & LSHTM Uganda Research Unit, MRC/UVRI & LSHTM Uganda Research Unit, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, University of Nairobi, University of Nairobi, UVRI-IAVI HIV Vaccine Program, University of Nairobi, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme, University of California, San Francisco (UCSF) - Department of Medicine, IAVI, University of Nairobi, London School of Hygiene & Tropical Medicine - Uganda Research Unit, University of Oxford, Imperial College London - IAVI Human Immunology Laboratory, University of Oxford - Oxford Vaccine Group, International AIDS Vaccine Initiative, Imperial College London - Department of Infectious Disease, University of Nairobi, London School of Hygiene & Tropical Medicine - Uganda Research Unit, Center for Family Health Research Zambia (CFHRZ), IAVI, Kenya Medical Research Institute (KEMRI) - Kemri-Wellcome Trust Research Programme and University of Oxford - The Jenner Institute
Downloads 185 (409,459)

Abstract:

Loading...

T cells, T-cell vaccine, HIV vaccine: conserved regions, phase I trial, HIVconsvX, ChAdOx1, MVA, vaccine safety, vaccine immunogenicity, clinical trial, virus inhibition assay, HIV-1

2.

Acceptability and Applicability of Biometric Iris Scanning for the Identification and Follow Up of Highly Mobile Research Participants Living in Fishing Communities Along the Shores of Lake Victoria in Kenya, Tanzania, and Uganda

Number of pages: 24 Posted: 29 Nov 2022
Mwanza Intervention Trials Unit, Mwanza Intervention Trials Unit, Kenya Medical Research Institute (KEMRI), UVRI-IAVI HIV Vaccine Program, London School of Hygiene & Tropical Medicine - Uganda Research Unit, International AIDS Vaccine Initiative, New York, Kenya Medical Research Institute (KEMRI), National Institute for Medical Research (NIMR) - Mwanza Medical Research Centre, Government of Uganda - Uganda Virus Research Institute (UVRI), UVRI-IAVI HIV Vaccine Program, International AIDS Vaccine Initiative, Kenya Medical Research Institute (KEMRI), UVRI-IAVI HIV Vaccine Program, Government of Uganda - Uganda Virus Research Institute (UVRI), International AIDS Vaccine Initiative, International AIDS Vaccine Initiative, Government of Uganda - Uganda Virus Research Institute (UVRI), Mwanza Intervention Trials Unit, London School of Hygiene & Tropical Medicine - Department of Global Health and Development and Mwanza Intervention Trials Unit
Downloads 51 (1,052,702)

Abstract:

Loading...

East Africa, fishing communities, Lake Victoria, acceptability, iris scanning, biometric identification

3.

Impact of Antimicrobials on Penile HIV Susceptibility and Immunology in Uncircumcised Men: A Randomized, Open-Label, Phase I/Ii Clinical Trial

Number of pages: 31 Posted: 16 Feb 2024
Rakai Health Science Program, UVRI-IAVI HIV Vaccine Program, George Washington University, Western University, Western University, Makerere University, UVRI-IAVI HIV Vaccine Program, University of Toronto, University of Toronto, UVRI-IAVI HIV Vaccine Program, UVRI-IAVI HIV Vaccine Program, UVRI-IAVI HIV Vaccine Program, UVRI-IAVI HIV Vaccine Program, UVRI-IAVI HIV Vaccine Program, Entebbe Regional Referral Hospital, University of Toronto, Johns Hopkins University - Department of Medicine, George Washington University, Western University, University of Toronto - University Health Network and Independent
Downloads 35 (1,249,711)

Abstract:

Loading...

HIV susceptibility, penile microbiome, penile immunology, randomized clinical trial, Uganda